Esperion Therapeutics, Inc.·4

Aug 8, 4:14 PM ET

Koenig Sheldon L. 4

4 · Esperion Therapeutics, Inc. · Filed Aug 8, 2022

Insider Transaction Report

Form 4
Period: 2022-08-05
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-08-05$5.80/sh+8,606$49,950198,771 total

Documents

1 file
  • 4
    wf-form4_165998966897265.xmlPrimary

    FORM 4